Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. (EHAB) is a premier provider of home health and hospice services in the United States. Committed to delivering care where patients prefer it most—right in their own homes—Enhabit operates through two main segments: Home Health and Hospice.
The Home Health segment offers a comprehensive range of Medicare-certified nursing services to adults in need of medical care. These services include skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. This segment is the cornerstone of Enhabit’s revenue generation, providing essential healthcare support that fosters improved quality of life and recovery in the comfort of patients’ homes.
The Hospice segment is dedicated to enhancing the quality of life for patients with advanced, life-limiting illnesses. This segment focuses on treating the person and their symptoms, rather than the disease itself, through personalized care plans and compassionate support. It ensures that patients receive comprehensive end-of-life care that prioritizes their comfort and dignity.
With a solid reputation for excellence in home-based healthcare, Enhabit continually strives to advance its services and reach. Recent achievements include strategic partnerships that expand service capabilities and innovative projects aimed at improving patient outcomes. Financially, the company remains robust, consistently investing in cutting-edge healthcare technologies and staff training to maintain high standards of care.
Enhabit’s commitment to patient-centered care, combined with its extensive service offerings, positions it as a significant player in the healthcare industry. For investors and stakeholders seeking the latest updates and performance metrics, staying informed about Enhabit's continuous developments and strategic initiatives is essential.
Encompass Health and Enhabit have won a significant lawsuit in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The Court also ruled against private equity firms Vistria Group and Nautic Partners for aiding these breaches.
The Court found that the defendants misappropriated acquisition opportunities, used confidential information, and recruited key employees while still employed at Encompass Health. As compensation, the Court awarded 43% of VitalCaring Group's profits to Encompass Health and Enhabit, plus $1.62 million in mitigation damages and attorneys' fees.
The defendants were found to have deliberately concealed their actions through falsifying records, deleting evidence, and manipulating communications. The Court's decision sends a clear message about the consequences of breaching fiduciary duties and self-dealing by corporate officers.
Encompass Health and Enhabit have won a significant legal victory in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The court found that while employed at Encompass Health, these officers misappropriated acquisition opportunities, used confidential information, and recruited employees for a competing venture.
The Court awarded damages against private equity firms Vistria Group and Nautic Partners for aiding these breaches. The remedy includes a constructive trust entitling Encompass Health and Enhabit to 43% of VitalCaring Group's profits and future exit proceeds, approximately $1.62 million in mitigation damages, and attorneys' fees due to defendants' bad faith conduct including evidence tampering.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, announced its participation in the BofA Securities 2024 Home Care Conference. President and CEO Barb Jacobsmeyer, incoming CFO Ryan Solomon, and SVP of Strategic Finance & Treasurer Jobie Williams will participate in a fireside chat on Tuesday, Dec. 10, at 9:00 a.m. EST. The event will be webcast live and available for replay on the company's investor website. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, leveraging advanced technology for patient care delivery.
Enhabit Home Health & Hospice (NYSE: EHAB) has appointed Ryan Solomon as its new Chief Financial Officer, effective Dec. 9, 2024. Solomon brings over 20 years of corporate strategy and finance experience, including eight years as CFO in home health and hospice. He previously served as CFO at AccentCare and Aspirion, where he managed financial planning, accounting, tax, treasury, revenue cycle, and corporate development. Solomon will replace Crissy Carlisle, the current CFO, as part of a previously announced transition. His experience includes building finance teams, systems integration, mergers and acquisitions, and operational business planning.
Enhabit Inc (NYSE: EHAB) reported Q3 2024 financial results with net service revenue of $253.6 million, down 1.8% year-over-year. The company reported a net loss of $110.2 million and Adjusted EBITDA of $24.5 million, up 5.6%. Home health segment saw non-Medicare admissions increase 20.1%, while hospice segment revenue grew 11% with average daily census up 6.9%. Due to lower recertifications and hurricane impacts, Enhabit revised its full-year 2024 guidance, with net service revenue now expected between $1,031-$1,046 million and Adjusted EBITDA between $98-$102 million.
Enhabit Home Health & Hospice (NYSE: EHAB) has been recognized as an Age-Friendly Health Systems Participant by the Institute for Healthcare Improvement (IHI). This recognition acknowledges Enhabit's commitment to implementing the 4Ms of Age-Friendly Care: What Matters, Medication, Mentation, and Mobility.
Bud Langham, executive vice president of clinical excellence & strategy at Enhabit, emphasized the company's dedication to providing the best possible care for older adults. The Age-Friendly Health Systems initiative, supported by The John A. Hartford Foundation and other partners, aims to improve care for older adults across various healthcare settings, including home-based care.
By participating in this movement, Enhabit joins a select group of healthcare systems worldwide working to tailor care to patients' goals and preferences, aligning with their vision of excellence in elder care.
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, has announced its participation in two upcoming investor conferences. The company's President and CEO Barb Jacobsmeyer and CFO Crissy Carlisle will attend:
- Jefferies Healthcare Services "Back to School" Summit and Bus Tour on Aug. 28 in Nashville, Tenn.
- 2024 Wells Fargo Healthcare Conference on Sept. 5 in Boston, Mass., including investor meetings and a fireside chat.
The fireside chat will be webcast live at 11 a.m. EDT and available for replay on Enhabit's investor website. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, focusing on expanding patient care possibilities in the home through advanced technology and compassionate teams.
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, has announced that CFO Crissy Carlisle will step down from her role. The company has initiated a comprehensive search for her successor. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities.
CEO Barb Jacobsmeyer praised Carlisle's contributions since Enhabit became a public company two years ago, highlighting her role in achieving business stability and positioning the organization for growth. Carlisle expressed pride in her accomplishments, including establishing a finance organization and enhancing the control environment.
Enhabit operates 256 home health locations and 112 hospice locations across 34 states. The company will hold a conference call to discuss its second quarter 2024 financial results.
Enhabit, Inc. (NYSE: EHAB) reported its Q2 2024 financial results, showing mixed performance across its home health and hospice segments. Key highlights include:
- Net service revenue of $260.6 million, down 0.6% year-over-year
- Net loss of $0.2 million, improved from a $74.4 million loss in Q2 2023
- Adjusted EBITDA of $25.2 million, up 5.4% year-over-year
- Earnings per share of $0.00, adjusted EPS of $0.07
The home health segment saw a 6.4% increase in total admissions, driven by a 25.2% growth in non-Medicare admissions. Hospice segment revenue grew 3.9%, with average daily census increasing 2.7% year-over-year. The company updated its full-year 2024 guidance, slightly lowering revenue expectations but maintaining its adjusted EBITDA forecast.
AREX Capital Management, LP, owning 4.9% of Enhabit, Inc. (NYSE: EHAB), announced the election of Mark W. Ohlendorf to Enhabit's board of directors at the 2024 Annual Meeting. AREX expressed satisfaction with this outcome, highlighting Ohlendorf's financial expertise as important for improving Enhabit's financial reporting and investor communications. The campaign emphasized Enhabit's poor performance in its first two years as a public company and proposed strategies for improvement. AREX stressed that this result should not be seen as approval of the status quo, noting significant stockholder support for change. Both leading proxy advisors recommended replacing three directors. AREX urged the board to focus on correcting Enhabit's undervaluation and improving stockholder outcomes.
FAQ
What is the current stock price of Enhabit (EHAB)?
What is the market cap of Enhabit (EHAB)?
What services does Enhabit, Inc. offer?
Where does Enhabit, Inc. operate?
How does Enhabit, Inc. generate most of its revenue?
What is unique about Enhabit’s Hospice services?
Why might investors be interested in Enhabit, Inc.?
What recent achievements has Enhabit, Inc. made?
How does Enhabit, Inc. ensure high standards of care?
What types of therapy services does Enhabit, Inc. provide?
How can patients benefit from Enhabit’s home health services?
What is the goal of Enhabit’s Hospice care?
